Parag Saxena
Director, 10% Owner · REVIVA PHARMACEUTICALS HOLDINGS, INC.
Individual
- 2024
- Dec 12, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Parag Saxena's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
- David Cordani - $60.11M in CI purchases and sales in the last 12 months
- AI DMI LLC - $59.87M in IRON purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $59.04M in SGP purchases and sales in the last 12 months
- Mark A. Goldsmith - $56.99M in RVMD purchases and sales in the last 12 months
- Peter A. Thompson - $55.67M in SION purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Parag Saxena?
Parag Saxena is a corporate insider, tracked as Director, 10% Owner of REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Parag Saxena last file a Form 4?
The only primary Form 4 on record is dated 12 December 2024.